Regorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard Therapy
Clinical trial NCT03305913 · COMPLETED
Trial details
- NCT number
- NCT03305913
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2018-10-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.